Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Articles by Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Latest Updated Articles
Rapid Readouts: Updated Results From KX-ORAX-001 StudyPublished: December 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5